Merck
MRK
#54
Rank
A$400.71 B
Marketcap
A$162.24
Share price
2.55%
Change (1 day)
36.44%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): A$5.49

According to Merck's latest financial reports the company's current EPS (TTM) is A$4.98. In 2025 the company made an earnings per share (EPS) of A$10.20 an increase over its 2024 EPS that were of A$9.46.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.49-46.22%
2025A$10.207.81%
2024A$9.464308.46%
2023A$0.21-97.32%
2022A$8.0210.92%
2021A$7.2384.68%
2020A$3.92-27.2%
2019A$5.3863.44%
2018A$3.29151.11%
2017A$1.31-54.58%
2016A$2.8930.21%
2015A$2.22-61.99%
2014A$5.83180.51%
2013A$2.08-31.82%
2012A$3.056.62%
2011A$2.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.23 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.83 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.83-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.05 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.52 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.27 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.58-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.98 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.44 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.92-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel